🇰🇷 South Korea Country × Condition
crohn s disease Clinical Trials in South Korea
Active clinical trials for crohn s disease with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT05428345
Recruiting
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Enrollment
600 pts
Country
🇰🇷 South Korea
Takeda
View Trial → NCT06064864
Recruiting
Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
Enrollment
100 pts
Country
🇰🇷 South Korea
Asan Medical Center
View Trial → Frequently Asked Questions
How many crohn s disease clinical trials are active in South Korea?
There are currently 2 active clinical trials for crohn s disease with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a crohn s disease clinical trial in South Korea?
To join a crohn s disease clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are crohn s disease trials in South Korea?
Active crohn s disease trials in South Korea span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology